-
1
-
-
0031561513
-
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
-
Jang, M.S. et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–220.
-
(1997)
Science
, vol.275
, pp. 218-220
-
-
Jang, M.S.1
-
2
-
-
0035451363
-
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation
-
Surh, Y.J. et al. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480: 243–268.
-
(2001)
Mutat. Res.
, vol.480
, pp. 243-268
-
-
Surh, Y.J.1
-
3
-
-
4644309893
-
Mechanisms of cardiovascular protection by resveratrol
-
Hao, H.D. & L.R. He. 2004. Mechanisms of cardiovascular protection by resveratrol. J. Med. Food 7: 290–298.
-
(2004)
J. Med. Food
, vol.7
, pp. 290-298
-
-
Hao, H.D.1
He, L.R.2
-
4
-
-
84862777886
-
Cardiovascular effects and molecular targets of resveratrol
-
Li, H.G., N. Xia & U. Förstermann. 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26: 102–110.
-
(2012)
Nitric Oxide
, vol.26
, pp. 102-110
-
-
Li, H.G.1
Xia, N.2
Förstermann, U.3
-
5
-
-
20344407841
-
Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications
-
de la Lastra, C.A. & I. Villegas. 2005. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49: 405–430.
-
(2005)
Mol. Nutr. Food Res.
, vol.49
, pp. 405-430
-
-
de la Lastra, C.A.1
Villegas, I.2
-
6
-
-
43549088782
-
Resveratrol—a multitargeted agent for age-associated chronic diseases
-
Harikumar, K.B. & B.B. Aggarwal. 2008. Resveratrol—a multitargeted agent for age-associated chronic diseases. Cell Cycle 7: 1020–1035.
-
(2008)
Cell Cycle
, vol.7
, pp. 1020-1035
-
-
Harikumar, K.B.1
Aggarwal, B.B.2
-
7
-
-
84867865164
-
Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action
-
Xu, Q. & L.Y. Si. 2012. Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action. Nutr. Res. 32: 648–658.
-
(2012)
Nutr. Res.
, vol.32
, pp. 648-658
-
-
Xu, Q.1
Si, L.Y.2
-
8
-
-
84863011114
-
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
-
Park, S.J. et al. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421–433.
-
(2012)
Cell
, vol.148
, pp. 421-433
-
-
Park, S.J.1
-
9
-
-
84870926998
-
Fruits and dietary phytochemicals in bone protection
-
Shen, C.L. et al. 2012. Fruits and dietary phytochemicals in bone protection. Nutr. Res. 32: 897–910.
-
(2012)
Nutr. Res.
, vol.32
, pp. 897-910
-
-
Shen, C.L.1
-
10
-
-
84878778128
-
Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement
-
Richer, S. et al. 2013. Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement. Nutrients 5: 1989–2005.
-
(2013)
Nutrients
, vol.5
, pp. 1989-2005
-
-
Richer, S.1
-
11
-
-
3943071801
-
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
-
Wood, J.G. et al. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686–689.
-
(2004)
Nature
, vol.430
, pp. 686-689
-
-
Wood, J.G.1
-
12
-
-
77952549960
-
Resveratrol, sirtuins, and the promise of a DR mimetic
-
Baur, J.A. 2010. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 131: 261–269.
-
(2010)
Mech. Ageing Dev.
, vol.131
, pp. 261-269
-
-
Baur, J.A.1
-
13
-
-
33845334891
-
Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro
-
Riviere, C. et al. 2007. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg. Med. Chem. 15: 1160–1167.
-
(2007)
Bioorg. Med. Chem.
, vol.15
, pp. 1160-1167
-
-
Riviere, C.1
-
14
-
-
77955088481
-
Resveratrol as a therapeutic agent for neurodegenerative diseases
-
Sun, A.Y. et al. 2010. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 41: 375–383.
-
(2010)
Mol. Neurobiol.
, vol.41
, pp. 375-383
-
-
Sun, A.Y.1
-
15
-
-
51349132313
-
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
-
Kundu, J.K. & Y.J. Surh. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett. 269: 243–261.
-
(2008)
Cancer Lett.
, vol.269
, pp. 243-261
-
-
Kundu, J.K.1
Surh, Y.J.2
-
17
-
-
34547684362
-
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
-
Shankar, S., G. Singh & R.K. Srivastava. 2007. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 12: 4839–4854.
-
(2007)
Front. Biosci.
, vol.12
, pp. 4839-4854
-
-
Shankar, S.1
Singh, G.2
Srivastava, R.K.3
-
18
-
-
84914689065
-
Resveratrol: anti-obesity mechanisms of action
-
Aguirre, L. et al. 2014. Resveratrol: anti-obesity mechanisms of action. Molecules 19: 18632–18655.
-
(2014)
Molecules
, vol.19
, pp. 18632-18655
-
-
Aguirre, L.1
-
19
-
-
78751706756
-
Resveratrol and cellular mechanisms of cancer prevention
-
&, ” In, O. Vang, &, D.K. Das, Eds., Malden, Wiley-Blackwell
-
Shukla, Y. & R. Singh. 2011. “Resveratrol and cellular mechanisms of cancer prevention.” In Resveratrol and Health. Vol. 1215: O. Vang & D.K. Das, Eds.: 1–8. Malden: Wiley-Blackwell.
-
(2011)
Resveratrol and Health
, vol.1215
, pp. 1-8
-
-
Shukla, Y.1
Singh, R.2
-
21
-
-
84923063732
-
Regulation of microRNAs by natural agents: new strategies in cancer therapies
-
Phuah, N.H. & N.H. Nagoor. 2014. Regulation of microRNAs by natural agents: new strategies in cancer therapies. BioMed Res. Int. 2014: 804510.
-
(2014)
BioMed Res. Int.
, vol.2014
, pp. 804510
-
-
Phuah, N.H.1
Nagoor, N.H.2
-
22
-
-
84866429138
-
Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects
-
Lancon, A. et al. 2012. Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects. J. Agric. Food Chem. 60: 8783–8789.
-
(2012)
J. Agric. Food Chem.
, vol.60
, pp. 8783-8789
-
-
Lancon, A.1
-
23
-
-
71749100220
-
AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols
-
Hwang, J.T., D.Y. Kwon & S.H. Yoon. 2009. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotech. 26: 17–22.
-
(2009)
New Biotech.
, vol.26
, pp. 17-22
-
-
Hwang, J.T.1
Kwon, D.Y.2
Yoon, S.H.3
-
24
-
-
5144223780
-
Molecular basis of chemoprevention by resveratrol: NF-kappa B and AP-1 as potential targets
-
Kundu, J.K. & Y.J. Surh. 2004. Molecular basis of chemoprevention by resveratrol: NF-kappa B and AP-1 as potential targets. Mutat. Res. 555: 65–80.
-
(2004)
Mutat. Res.
, vol.555
, pp. 65-80
-
-
Kundu, J.K.1
Surh, Y.J.2
-
25
-
-
84883340186
-
Resveratrol as a Pan-HDAC inhibitor alters the acetylation status of jistone proteins in human-derived hepatoblastoma cells
-
Venturelli, S. et al. 2013. Resveratrol as a Pan-HDAC inhibitor alters the acetylation status of jistone proteins in human-derived hepatoblastoma cells. PLoS One 8: 12.
-
(2013)
PLoS One
, vol.8
-
-
Venturelli, S.1
-
26
-
-
0034909129
-
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
-
Gusman, J., H. Malonne & G. Atassi. 2001. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22: 1111–1117.
-
(2001)
Carcinogenesis
, vol.22
, pp. 1111-1117
-
-
Gusman, J.1
Malonne, H.2
Atassi, G.3
-
27
-
-
0036130351
-
Inactivation of creatine kinase induced by stilbene derivatives
-
Miura, T., S. Muraoka & Y. Fujimoto. 2002. Inactivation of creatine kinase induced by stilbene derivatives. Pharmacol. Toxicol. 90: 66–72.
-
(2002)
Pharmacol. Toxicol.
, vol.90
, pp. 66-72
-
-
Miura, T.1
Muraoka, S.2
Fujimoto, Y.3
-
28
-
-
4644302857
-
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship
-
Murias, M. et al. 2004. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 12: 5571–5578.
-
(2004)
Bioorg. Med. Chem.
, vol.12
, pp. 5571-5578
-
-
Murias, M.1
-
29
-
-
52649086870
-
Resveratrol directly targets COX-2 to inhibit carcinogenesis
-
Zykova, T.A. et al. 2008. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinog. 47: 797–805.
-
(2008)
Mol. Carcinog.
, vol.47
, pp. 797-805
-
-
Zykova, T.A.1
-
30
-
-
84903782541
-
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models
-
Xu, L.H. et al. 2014. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci. Transl. Med. 6: 12.
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 12
-
-
Xu, L.H.1
-
31
-
-
84855556537
-
Aspirin in the chemoprevention of colorectal neoplasia: an overview
-
Chan, A.T. et al. 2012. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev. Res. 5: 164–178.
-
(2012)
Cancer Prev. Res.
, vol.5
, pp. 164-178
-
-
Chan, A.T.1
-
32
-
-
77953319891
-
COX-2 as a target for cancer chemotherapy
-
Ghosh, N. et al. 2010. COX-2 as a target for cancer chemotherapy. Pharmacol. Rep. 62: 233–244.
-
(2010)
Pharmacol. Rep.
, vol.62
, pp. 233-244
-
-
Ghosh, N.1
-
33
-
-
77954701127
-
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
-
Calamini, B. et al. 2010. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 429: 273–282.
-
(2010)
Biochem. J.
, vol.429
, pp. 273-282
-
-
Calamini, B.1
-
35
-
-
78649927272
-
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A(4) hydrolase
-
Oi, N. et al. 2010. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A(4) hydrolase. Cancer Res. 70: 9755–9764.
-
(2010)
Cancer Res.
, vol.70
, pp. 9755-9764
-
-
Oi, N.1
-
36
-
-
77957344556
-
A critical role for LTA(4)H in limiting chronic pulmonary neutrophilic inflammation
-
Snelgrove, R.J. et al. 2010. A critical role for LTA(4)H in limiting chronic pulmonary neutrophilic inflammation. Science 330: 90–94.
-
(2010)
Science
, vol.330
, pp. 90-94
-
-
Snelgrove, R.J.1
-
37
-
-
84875890762
-
Targeting cellular metabolism to improve cancer therapeutics
-
Zhao, Y., E.B. Butler & M. Tan. 2013. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 4: 10.
-
(2013)
Cell Death Dis.
, vol.4
, pp. 10
-
-
Zhao, Y.1
Butler, E.B.2
Tan, M.3
-
38
-
-
77950605484
-
Fatty acid synthase as a potential therapeutic target in cancer
-
Flavin, R. et al. 2010. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 6: 551–562.
-
(2010)
Future Oncol.
, vol.6
, pp. 551-562
-
-
Flavin, R.1
-
39
-
-
33745728461
-
Fatty acid synthase and cancer: new application of an old pathway
-
Kuhajda, F.P. 2006. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 66: 5977–5980.
-
(2006)
Cancer Res.
, vol.66
, pp. 5977-5980
-
-
Kuhajda, F.P.1
-
40
-
-
32944475076
-
Structure-activity relationship of polyphenols that inhibit fatty acid synthase
-
Li, B.H. et al. 2005. Structure-activity relationship of polyphenols that inhibit fatty acid synthase. J. Biochem. 138: 679–685.
-
(2005)
J. Biochem.
, vol.138
, pp. 679-685
-
-
Li, B.H.1
-
41
-
-
82955178161
-
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
-
Pandey, P.R. et al. 2011. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res. Treat. 130: 387–398.
-
(2011)
Breast Cancer Res. Treat.
, vol.130
, pp. 387-398
-
-
Pandey, P.R.1
-
42
-
-
84885454938
-
Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence
-
Patel, K.R. et al. 2013. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci. Transl. Med. 5: 12.
-
(2013)
Sci. Transl. Med.
, vol.5
, pp. 12
-
-
Patel, K.R.1
-
43
-
-
84884544164
-
Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4′–Amino-3,5-dihydroxy-trans-stilbene
-
Ito, Y. et al. 2013. Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4′–Amino-3,5-dihydroxy-trans-stilbene. J. Nutr. Sci. Vitaminol. 59: 358–364.
-
(2013)
J. Nutr. Sci. Vitaminol.
, vol.59
, pp. 358-364
-
-
Ito, Y.1
-
44
-
-
4544327822
-
Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography
-
Wang, Z.R. et al. 2004. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem. Biophys. Res. Commun. 323: 743–749.
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.323
, pp. 743-749
-
-
Wang, Z.R.1
-
45
-
-
4444267291
-
Crystal structure of quinone reductase 2 in complex with resveratrol
-
Buryanovskyy, L. et al. 2004. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43: 11417–11426.
-
(2004)
Biochemistry
, vol.43
, pp. 11417-11426
-
-
Buryanovskyy, L.1
-
46
-
-
42449128395
-
Association of NRH: quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease
-
Wang, W., W-D. Le, T. Pan, et al. 2008. Association of NRH: quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease. J. Gerontol. A Biol. Sci. Med. Sci. 63: 127–134.
-
(2008)
J. Gerontol. A Biol. Sci. Med. Sci.
, vol.63
, pp. 127-134
-
-
Wang, W.1
Le, W.-D.2
Pan, T.3
-
47
-
-
43549098380
-
Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols
-
Neves, M.A.C. et al. 2007. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols. ChemMedChem. 2: 1750–1762.
-
(2007)
ChemMedChem.
, vol.2
, pp. 1750-1762
-
-
Neves, M.A.C.1
-
48
-
-
40549083326
-
Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography
-
Hsieh, T.C. et al. 2008. Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography. Anticancer Res. 28: 29–36.
-
(2008)
Anticancer Res.
, vol.28
, pp. 29-36
-
-
Hsieh, T.C.1
-
49
-
-
85047685824
-
Peroxisome proliferator-activated receptor gamma and lung cancer biology
-
Roman, J. 2008. Peroxisome proliferator-activated receptor gamma and lung cancer biology. J. Invest. Med. 56: 528–533.
-
(2008)
J. Invest. Med.
, vol.56
, pp. 528-533
-
-
Roman, J.1
-
50
-
-
33751072349
-
Resveratrol improves health and survival of mice on a high-calorie diet
-
Baur, J.A. et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337–342.
-
(2006)
Nature
, vol.444
, pp. 337-342
-
-
Baur, J.A.1
-
51
-
-
84901507127
-
Resveratrol and its metabolites bind to PPARs
-
Calleri, E. et al. 2014. Resveratrol and its metabolites bind to PPARs. ChemBioChem. 15: 1154–1160.
-
(2014)
ChemBioChem.
, vol.15
, pp. 1154-1160
-
-
Calleri, E.1
-
52
-
-
84925758089
-
Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview
-
Heckman, P.R.A., C. Wouters & J. Prickaerts. 2015. Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview. Curr. Pharm. Design 21: 317–331.
-
(2015)
Curr. Pharm. Design
, vol.21
, pp. 317-331
-
-
Heckman, P.R.A.1
Wouters, C.2
Prickaerts, J.3
-
53
-
-
70449109739
-
Phosphodiesterase inhibition in heart failure
-
Movsesian, M. et al. 2009. Phosphodiesterase inhibition in heart failure. Heart Fail. Rev. 14: 255–263.
-
(2009)
Heart Fail. Rev.
, vol.14
, pp. 255-263
-
-
Movsesian, M.1
-
54
-
-
84890686350
-
Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD
-
Tashkin, D.P. 2014. Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD. Expert Opin. Pharmacother. 15: 85–96.
-
(2014)
Expert Opin. Pharmacother.
, vol.15
, pp. 85-96
-
-
Tashkin, D.P.1
-
55
-
-
67349128956
-
Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms
-
Athar, M. et al. 2009. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 486: 95–102.
-
(2009)
Arch. Biochem. Biophys.
, vol.486
, pp. 95-102
-
-
Athar, M.1
-
56
-
-
33645765580
-
Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols
-
Jo, J.Y., E.G. De Mejia & M.A. Lila. 2006. Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols. J. Agric. Food Chem. 54: 2083–2087.
-
(2006)
J. Agric. Food Chem.
, vol.54
, pp. 2083-2087
-
-
Jo, J.Y.1
De Mejia, E.G.2
Lila, M.A.3
-
57
-
-
0037295102
-
Molecular mechanism of the chemopreventive effect of resveratrol
-
Dong, Z. 2003. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat. Res. 523: 145–150.
-
(2003)
Mutat. Res.
, vol.523
, pp. 145-150
-
-
Dong, Z.1
-
58
-
-
34250788809
-
AKT/PKB signaling: Navigating downstream
-
Manning, B.D. & L.C. Cantley. 2007. AKT/PKB signaling: Navigating downstream. Cell 129: 1261–1274.
-
(2007)
Cell
, vol.129
, pp. 1261-1274
-
-
Manning, B.D.1
Cantley, L.C.2
-
59
-
-
84903388632
-
Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2
-
Hsieh, T.C. et al. 2014. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2. PLoS One 9: 1.
-
(2014)
PLoS One
, vol.9
-
-
Hsieh, T.C.1
-
60
-
-
27844553839
-
AKT crystal structure and AKT-specific inhibitors
-
Kumar, C.C. & V. Madison. 2005. AKT crystal structure and AKT-specific inhibitors. Oncogene 24: 7493–7501.
-
(2005)
Oncogene
, vol.24
, pp. 7493-7501
-
-
Kumar, C.C.1
Madison, V.2
-
61
-
-
67650073265
-
Cell cycle kinases as therapeutic targets for cancer
-
Lapenna, S. & A. Giordano. 2009. Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8: 547–566.
-
(2009)
Nat. Rev. Drug Discov.
, vol.8
, pp. 547-566
-
-
Lapenna, S.1
Giordano, A.2
-
62
-
-
84903220507
-
Direct activation of ATM by resveratrol under oxidizing conditions
-
Lee, J.H. et al. 2014. Direct activation of ATM by resveratrol under oxidizing conditions. PLoS One 9: 10.
-
(2014)
PLoS One
, vol.9
-
-
Lee, J.H.1
-
63
-
-
0035933774
-
Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol
-
Stivala, L.A. et al. 2001. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276: 22586–22594.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 22586-22594
-
-
Stivala, L.A.1
-
65
-
-
0037454696
-
Inhibition of protein kinase C by resveratrol
-
Slater, S.J. et al. 2003. Inhibition of protein kinase C by resveratrol. Biochim. Biophys. Acta-Mol. Basis Dis. 1637: 59–69.
-
(2003)
Biochim. Biophys. Acta-Mol. Basis Dis.
, vol.1637
, pp. 59-69
-
-
Slater, S.J.1
-
66
-
-
0034333325
-
Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases—inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation
-
Stewart, J.R., K.L. Christman & C.A. O'Brian. 2000. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases—inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem. Pharmacol. 60: 1355–1359.
-
(2000)
Biochem. Pharmacol.
, vol.60
, pp. 1355-1359
-
-
Stewart, J.R.1
Christman, K.L.2
O'Brian, C.A.3
-
68
-
-
80051986980
-
Emerging roles of protein kinase D1 in cancer
-
Sundram, V., S.C. Chauhan & M. Jaggi. 2011. Emerging roles of protein kinase D1 in cancer. Mol. Cancer Res. 9: 985–996.
-
(2011)
Mol. Cancer Res.
, vol.9
, pp. 985-996
-
-
Sundram, V.1
Chauhan, S.C.2
Jaggi, M.3
-
69
-
-
0035894173
-
Inhibition of protein kinase D by resveratrol
-
Haworth, R.S. & M. Avkiran. 2001. Inhibition of protein kinase D by resveratrol. Biochem. Pharmacol. 62: 1647–1651.
-
(2001)
Biochem. Pharmacol.
, vol.62
, pp. 1647-1651
-
-
Haworth, R.S.1
Avkiran, M.2
-
70
-
-
84925503952
-
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
-
Sajish, M. & P. Schimmel. 2015. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 519: 370–373.
-
(2015)
Nature
, vol.519
, pp. 370-373
-
-
Sajish, M.1
Schimmel, P.2
-
71
-
-
84908530414
-
Chemical con artists foil drug discovery
-
Baell, J. & M.A. Walters. 2014. Chemical con artists foil drug discovery. Nature 513: 481–483.
-
(2014)
Nature
, vol.513
, pp. 481-483
-
-
Baell, J.1
Walters, M.A.2
-
72
-
-
85006291818
-
-
Accessed May 28, 2015
-
MRC. 2014. Kinase Inhibitor Database. Vol. 2014 http://www.kinase-screen.mrc.ac.uk/screening-compounds/345920. Accessed May 28, 2015.
-
(2014)
Kinase Inhibitor Database
, vol.2014
-
-
-
73
-
-
36048958965
-
Histone deacetylase inhibitors: overview and perspectives
-
Dokmanovic, M., C. Clarke & P.A. Marks. 2007. Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 5: 981–989.
-
(2007)
Mol. Cancer Res.
, vol.5
, pp. 981-989
-
-
Dokmanovic, M.1
Clarke, C.2
Marks, P.A.3
-
74
-
-
84861852370
-
Are sirtuins viable targets for improving healthspan and lifespan
-
Baur, J.A. et al. 2012. Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discov. 11: 443–461.
-
(2012)
Nat. Rev. Drug Discov.
, vol.11
, pp. 443-461
-
-
Baur, J.A.1
-
75
-
-
70350524083
-
Resveratrol is not a direct activator of SIRT1 enzyme activity
-
Beher, D. et al. 2009. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 74: 619–624.
-
(2009)
Chem. Biol. Drug Des.
, vol.74
, pp. 619-624
-
-
Beher, D.1
-
76
-
-
20444444649
-
Mechanism of human SIRT1 activation by resveratrol
-
Borra, M.T., B.C. Smith & J.M. Denu. 2005. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280: 17187–17195.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 17187-17195
-
-
Borra, M.T.1
Smith, B.C.2
Denu, J.M.3
-
77
-
-
84890257356
-
Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase
-
Liang, Y., W.X. Tian & X.F. Ma. 2013. Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase. BMC Complement Altern. Med. 13: 8.
-
(2013)
BMC Complement Altern. Med.
, vol.13
, pp. 8
-
-
Liang, Y.1
Tian, W.X.2
Ma, X.F.3
-
78
-
-
20444485396
-
Interaction of resveratrol and genistein with nucleic acids
-
Usha, S., I.M. Johnson & R. Malathi. 2005. Interaction of resveratrol and genistein with nucleic acids. J. Biochem. Mol. Biol. 38: 198–205.
-
(2005)
J. Biochem. Mol. Biol.
, vol.38
, pp. 198-205
-
-
Usha, S.1
Johnson, I.M.2
Malathi, R.3
-
80
-
-
35348865444
-
Mechanism of inhibition of bovine F-1-ATPase by resveratrol and related polyphenols
-
Gledhill, J.R. et al. 2007. Mechanism of inhibition of bovine F-1-ATPase by resveratrol and related polyphenols. Proc. Natl. Acad. Sci. U. S. A. 104: 13632–13637.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 13632-13637
-
-
Gledhill, J.R.1
|